Common variable immunodeficiency with autoantibodies to B- or T-cells
ICD-10 D83.2 is a billable code used to indicate a diagnosis of common variable immunodeficiency with autoantibodies to b- or t-cells.
Common variable immunodeficiency (CVID) is a primary immunodeficiency disorder characterized by low levels of serum immunoglobulins and an increased susceptibility to infections. In patients with D83.2, the condition is further complicated by the presence of autoantibodies that target B- or T-cells, leading to autoimmune manifestations. These autoantibodies can disrupt normal immune function, resulting in a range of complications including autoimmune hemolytic anemia, thrombocytopenia, and lymphoproliferative disorders. Clinically, patients may present with recurrent infections, chronic diarrhea, and respiratory issues. Diagnosis typically involves serological testing to assess immunoglobulin levels, along with specific tests for autoantibodies. Management often includes immunoglobulin replacement therapy and immunosuppressive agents to control autoimmune symptoms. Regular monitoring for complications is essential to improve patient outcomes.
Detailed immunological assessments, including immunoglobulin levels and autoantibody tests.
Patients presenting with recurrent infections and autoimmune symptoms.
Ensure comprehensive documentation of all immunological tests and treatment responses.
Complete blood counts, reticulocyte counts, and documentation of any hematologic complications.
Patients with autoimmune hemolytic anemia or thrombocytopenia.
Document any transfusions or treatments related to hematologic conditions.
Used for obtaining blood samples for immunological testing.
Document the reason for blood collection and any relevant patient history.
Ensure that the specialty performing the test is clearly documented.
Common symptoms include recurrent infections, chronic diarrhea, fatigue, and signs of autoimmune disorders such as anemia or thrombocytopenia.
Diagnosis is made through clinical evaluation, immunoglobulin level testing, and detection of autoantibodies against B- or T-cells.
